XML 47 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash Flows From Operating Activities    
Net loss $ (16,334,615) $ (17,036,837)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 2,742,162 687,845
Bad debt expense 927,847 12,000
Gain on forgiveness of debt (24,925) (376,177)
Equity based compensation expense 5,400,975 3,212,772
Recognized loss on marketable securities 1,424 22,416
Marketable securities distributed as compensation 0 3,917
Expenses paid through financings 0 32,500
Loan principal paid directly through grant (2,992) (8,853)
Amortization of debt discount and debt costs 2,503,160 1,840,745
Modification of derivative 12,624 0
Initial derivative expense 3,585,983 3,340,554
Change in derivative value due to anti-dilution adjustments 0 2,642,175
Change in fair value of derivative liability (7,315,580) 2,658,261
Impairment expense 2,530,325 0
Change in fair value of earn-out liability 35,294 0
Changes in assets and liabilities:    
Increase in accounts receivable (4,690,668) (94,767)
Increase in accounts receivable - related parties (7,909) (36,784)
Increase in prepaid expenses and other current assets (74,742) (68,542)
Increase in accounts payable and accrued liabilities 1,991,446 626,895
Decrease in accounts payable and accrued liabilities - related parties (746,756) (63,863)
Decrease in deferred payroll taxes (77,304) 0
Increase in other liabilities 2,840 173,525
Increase (decrease) in deferred revenue 525,767 (93,937)
Net cash used in operating activities (9,015,644) (2,526,155)
Cash Flows From Investing Activities:    
Proceeds from sale of marketable securities 0 17,009
Cash paid for acquisitions, net of cash acquired (2,238,958) 0
Cash paid for customer contracts 0 (50,000)
Net cash used in investing activities (2,238,958) (32,991)
Cash Flows From Financing Activities:    
Proceeds from loans 250,000 398,545
Proceeds from convertible notes 2,153,200 2,476,000
Deferred offering costs (78,038) 0
Payments of loans (723,611) (17,907)
Advances on receivables 0 180,778
Repayments of advances on receivables 0 (180,778)
Repayments of sale of future revenues $ (10,904) (528,838)
Proceeds from common shares and warrants 13,800,000  
Offering costs $ (1,651,889) 0
Proceeds from sale of preferred stock 0 25,000
Net cash provided by financing activities 13,738,758 2,352,800
Net increase (decrease) in cash 2,484,156 (206,346)
Cash, beginning of year 99,906 306,252
Cash, end of year 2,584,062 99,906
Supplemental disclosures of cash flow information:    
Cash paid during the year for interest 240,980 235,813
Cash paid during the year for income taxes 0 0
Supplemental schedule of non-cash investing and financing activities:    
Original issue discount deducted from convertible note proceeds 342,554 328,125
Debt costs deducted from convertible note proceeds 334,800 366,500
Notes and accrued interest converted to common stock 4,557,718 96,000
Notes payable and accrued interest exchanged for debentures 252,430 0
Accounts payable paid with common stock 140,000 0
Accrued compensation paid with common stock 16,425 0
Warrant derivative liability extinguished 10,182,476 0
Write off of right-of-use asset and lease liability 103,953 0
Deferred offering costs charged to additional paid-in capital 78,038 0
Common stock issued/to be issued for asset acquisitions 11,340,284 0
Earn-out liability consideration for acquisition 543,297 0
Loans issued as consideration for acquisitions 4,750,000 0
Shares issued for Upsider earn-out liability 1,394,768 0
Preferred stock issued for accrued penalties 0 1,929,516
Warrant derivative liability at inception 2,374,076 5,625,519
Prepayment of shares issued for services $ 237,382 $ 0